{
  "id": 20798613,
  "title": "Natera vs. Tempus AI: Which Blood Test Pioneer Has the Better Stock Buy for 2027?",
  "url": "https://urgent.news/2026/11/19/natera-vs-tempus-ai-which-blood-test-pioneer-has-the-better-stock-buy",
  "topic": "ai",
  "section": "AI",
  "published": "2026-11-19T19:40:02.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/natera-vs-tempus-ai-which-blood-test-pioneer-has-better-stock-buy-2027"
  },
  "original_language": "en",
  "account": null,
  "summary": "Key PointsNatera dominates the molecular diagnostics market with high revenue growth and positive free cash flow.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}